163 related articles for article (PubMed ID: 8817691)
1. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging.
Mohan S; Farley JR; Baylink DJ
Prog Growth Factor Res; 1995; 6(2-4):465-73. PubMed ID: 8817691
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
5. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions.
Kveiborg M; Flyvbjerg A; Rattan SI; Kassem M
Exp Gerontol; 2000 Oct; 35(8):1061-74. PubMed ID: 11121690
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases.
Mohan S; Baylink DJ
Endocrine; 1997 Aug; 7(1):87-91. PubMed ID: 9449039
[TBL] [Abstract][Full Text] [Related]
7. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
9. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.
Nicolas V; Mohan S; Honda Y; Prewett A; Finkelman RD; Baylink DJ; Farley JR
Calcif Tissue Int; 1995 Sep; 57(3):206-12. PubMed ID: 8574938
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
[TBL] [Abstract][Full Text] [Related]
12. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
Nanba K; Nagake Y; Miyatake N; Nakao K; Akagi S; Sugimoto T; Yamasaki H; Oishi K; Ichikawa H; Makino H
Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
[TBL] [Abstract][Full Text] [Related]
13. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
[TBL] [Abstract][Full Text] [Related]
15. Evidence that IGF-binding protein-5 functions as a growth factor.
Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
[TBL] [Abstract][Full Text] [Related]
17. IGF-I, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls.
Rooman RP; De Beeck LO; Martin M; Van Doorn J; Mohan S; Du Caju MV
Eur J Endocrinol; 2002 Jun; 146(6):823-9. PubMed ID: 12039703
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.
Ueland T; Brixen K; Mosekilde L; Mosekilde L; Flyvbjerg A; Bollerslev J
J Clin Endocrinol Metab; 2003 Mar; 88(3):1014-8. PubMed ID: 12629078
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
20. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
